Related Experiment Video
Updated: May 21, 2026

Oral Gavage in Neonatal Mouse Pups and Functional Assessment of Gut Barrier Integrity Using Ussing Chambers
Published on: January 9, 2026
Problems with the new born screen for galactosaemia
John I Malone1, Alicia Diaz-Thomas, Kathleen Swan
1Department of Pediatrics, University of South Florida, Tampa, Florida, USA. jmalone@hsc.usf.edu
Insights
Newborn screening for classical galactosaemia is crucial for early detection. Prompt dietary changes, removing lactose and galactose, significantly improve outcomes for affected infants.
Area of Science:
- Biochemistry
- Genetics
- Pediatrics
Background:
- Newborn screening aims to detect serious genetic disorders in asymptomatic infants before irreversible damage occurs.
- Classical galactosaemia is a severe inherited metabolic disorder that can lead to liver failure and other complications if not identified early.
Observation:
- A family experienced two children with classical galactosaemia, with the first child missed by newborn screening, leading to liver failure and transplant.
- The second child presented with similar symptoms but was identified by newborn screening due to reduced galactose-1-phosphate uridyl transferase activity.
Findings:
- Early detection through newborn screening and immediate dietary intervention (lactose and galactose restriction) led to significant clinical improvement in the second child.
- A critical factor in screening accuracy involves ensuring the patient has only native red blood cells when measuring enzyme activity for inborn genetic defects.
Implications:
- This case highlights the importance of robust newborn screening programs for identifying classical galactosaemia.
- Physicians must be aware of potential screening test failures, particularly concerning red blood cell integrity, to prevent diagnostic errors and ensure timely treatment.
Abstract:
The new born screen should identify asymptomatic children with a devastating disorder before the damage has occurred. One family had two children born with classical galactosaemia. The first child, subject to a flaw in the newborn screening program, was not detected, went into rapid liver failure and ultimately had a liver transplant. The second child was following the same devastating course when identified by the new born screen with reduced galactose-1-phosphate uridyl transferase activity in a blood spot. The rapid response of the second child to removal of lactose and galactose from the diet resulted in significant clinical improvement. If the screening test for an inborn genetic defect involves the measurement of enzyme activity in red blood cells, be sure the patient has only native red blood cells. The events leading to the failure of the galactosaemia screening test are reviewed, so physicians will be aware and avoid this problem.
Related Concept Videos
Glucose Transporters
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Inborn Errors of Metabolism
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Glucose Absorption Into the Small Intestine

